NVCR logo

NovoCure Limited (NVCR) Shareholders Equity

Annual Shareholders Equity:

$360.18M-$2.32M(-0.64%)
December 31, 2024

Summary

  • As of today, NVCR annual stockholders equity is $360.18 million, with the most recent change of -$2.32 million (-0.64%) on December 31, 2024.
  • During the last 3 years, NVCR annual shareholders equity has fallen by -$50.31 million (-12.26%).
  • NVCR annual shareholders equity is now -24.42% below its all-time high of $476.53 million, reached on December 31, 2020.

Performance

NVCR Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVCRbalance sheet metrics

Quarterly Shareholders Equity:

$341.33M-$8.11M(-2.32%)
September 30, 2025

Summary

  • As of today, NVCR quarterly stockholders equity is $341.33 million, with the most recent change of -$8.11 million (-2.32%) on September 30, 2025.
  • Over the past year, NVCR quarterly shareholders equity has dropped by -$19.45 million (-5.39%).
  • NVCR quarterly shareholders equity is now -28.37% below its all-time high of $476.53 million, reached on December 31, 2020.

Performance

NVCR Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVCRbalance sheet metrics

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

NVCR Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-0.6%-5.4%
3Y3 Years-12.3%-23.4%
5Y5 Years+65.4%+11.2%

NVCR Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-18.4%at low-23.4%at low
5Y5-Year-24.4%+65.4%-28.4%+11.2%
All-TimeAll-Time-24.4%+268.0%-28.4%+346.7%

NVCR Shareholders Equity History

DateAnnualQuarterly
Sep 2025
-
$341.33M(-2.3%)
Jun 2025
-
$349.44M(-3.5%)
Mar 2025
-
$361.96M(+0.5%)
Dec 2024
$360.18M(-0.6%)
$360.18M(-0.2%)
Sep 2024
-
$360.78M(-0.3%)
Jun 2024
-
$361.75M(+0.7%)
Mar 2024
-
$359.36M(-0.9%)
Dec 2023
$362.50M(-17.8%)
$362.50M(-7.9%)
Sep 2023
-
$393.70M(-5.3%)
Jun 2023
-
$415.68M(-3.8%)
Mar 2023
-
$432.15M(-2.0%)
Dec 2022
$441.17M(+7.5%)
$441.17M(-0.9%)
Sep 2022
-
$445.40M(+0.8%)
Jun 2022
-
$441.67M(+1.3%)
Mar 2022
-
$435.88M(+6.2%)
Dec 2021
$410.49M(-13.9%)
$410.49M(-0.6%)
Sep 2021
-
$413.16M(+4.0%)
Jun 2021
-
$397.27M(+6.8%)
Mar 2021
-
$372.13M(-21.9%)
Dec 2020
$476.53M
$476.53M(+55.2%)
Sep 2020
-
$307.04M(+14.6%)
Jun 2020
-
$267.82M(+10.7%)
DateAnnualQuarterly
Mar 2020
-
$241.95M(+11.1%)
Dec 2019
$217.79M(+94.0%)
$217.79M(+14.4%)
Sep 2019
-
$190.37M(+19.8%)
Jun 2019
-
$158.91M(+25.7%)
Mar 2019
-
$126.39M(+12.6%)
Dec 2018
$112.26M(-1.1%)
$112.26M(-2.3%)
Sep 2018
-
$114.94M(+2.5%)
Jun 2018
-
$112.08M(+5.6%)
Mar 2018
-
$106.12M(-6.6%)
Dec 2017
$113.56M(-20.2%)
$113.56M(-2.7%)
Sep 2017
-
$116.69M(-0.7%)
Jun 2017
-
$117.55M(-8.8%)
Mar 2017
-
$128.90M(-9.4%)
Dec 2016
$142.34M(-43.2%)
$142.34M(-10.0%)
Sep 2016
-
$158.24M(-15.2%)
Jun 2016
-
$186.65M(-15.3%)
Mar 2016
-
$220.43M(-12.1%)
Dec 2015
$250.82M(+156.3%)
$250.82M(+106.9%)
Sep 2015
-
$121.22M(-16.0%)
Jun 2015
-
$144.31M(+88.8%)
Mar 2015
-
$76.42M(-21.9%)
Dec 2014
$97.88M(-43.0%)
$97.88M
Dec 2013
$171.78M
-

FAQ

  • What is NovoCure Limited annual stockholders equity?
  • What is the all-time high annual shareholders equity for NovoCure Limited?
  • What is NovoCure Limited annual shareholders equity year-on-year change?
  • What is NovoCure Limited quarterly stockholders equity?
  • What is the all-time high quarterly shareholders equity for NovoCure Limited?
  • What is NovoCure Limited quarterly shareholders equity year-on-year change?

What is NovoCure Limited annual stockholders equity?

The current annual shareholders equity of NVCR is $360.18M

What is the all-time high annual shareholders equity for NovoCure Limited?

NovoCure Limited all-time high annual stockholders equity is $476.53M

What is NovoCure Limited annual shareholders equity year-on-year change?

Over the past year, NVCR annual stockholders equity has changed by -$2.32M (-0.64%)

What is NovoCure Limited quarterly stockholders equity?

The current quarterly shareholders equity of NVCR is $341.33M

What is the all-time high quarterly shareholders equity for NovoCure Limited?

NovoCure Limited all-time high quarterly stockholders equity is $476.53M

What is NovoCure Limited quarterly shareholders equity year-on-year change?

Over the past year, NVCR quarterly stockholders equity has changed by -$19.45M (-5.39%)
On this page